Basic Materials / Specialty ChemicalsKSE
$1778.00
-3.00 (-0.17%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 16%
FCF escenarios
weak_data · normalized FCF $-3.6B · quality 33.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
25/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$29.7B
P/E
13.1x
↓EV/EBITDA
14.9x
↑ROE
5.1%
↑Gross Margin
15.8%
↓Debt/Equity
1.12
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-4.0%
FCF CAGR
—
FCF margin
-37.4%
FCF / Net income
-10.76x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $46.63B · net income $1.62B · FCF $-17.46B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $46.63B | $46.63B | $54.04B | $54.51B | $52.72B |
| Net Income | $1.62B | $1.62B | $3.16B | $3.66B | $3.49B |
| EBITDA | $3.82B | $3.82B | $6.26B | $6.49B | $5.58B |
| EPS | 135.79 | 135.79 | 264.86 | 306.77 | 292.52 |
| Gross Margin | 15.8% | 15.8% | 17.7% | 17.3% | 16.0% |
| Operating Margin | 3.9% | 3.9% | 7.3% | 7.3% | 6.2% |
| Net Margin | 3.5% | 3.5% | 5.9% | 6.7% | 6.6% |
| Balance Sheet | |||||
| Debt/Equity | 1.12 | 1.12 | 0.51 | 0.33 | 0.21 |
| Current Ratio | 1.39 | 1.39 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-17.46B | $-17.46B | $-3.58B | $-1.08B | $3.67B |
| Returns | |||||
| ROE | 5.1% | 5.1% | 9.7% | 11.4% | 11.4% |
| Valuation | |||||
| P/E | 13.09 | 13.09 | 27.56 | 20.83 | 15.43 |
| EV/EBITDA | 14.89 | 14.89 | 16.43 | 13.17 | 10.78 |
| P/B | 0.67 | 0.67 | 2.66 | 2.37 | 1.76 |
| Growth & Yield | |||||
| Revenue Growth | -13.7% | -13.7% | -0.9% | 3.4% | — |
| EPS Growth | -48.7% | -48.7% | -13.7% | 4.9% | — |
| Dividend Yield | 4.7% | 4.7% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
5.1%
EPS terminal req.
$157.77
Spread vs growth
-53.9%
5Y implied EPS CAGR
7.1%
EPS terminal req.
$190.90
Spread vs growth
-55.8%
10Y implied EPS CAGR
8.5%
EPS terminal req.
$307.44
Spread vs growth
-57.2%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-51.9%
Start / end P/E
15.5x → 13.1x
EPS bridge
264.86 → 135.79
Residual
+7.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.